Additional file 1: of EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy
Figure S1. Immunological activation profile of EnanDIM-C in comparison to the common PTO-modified CpG-ODN CpG 7909 (ProMune). In vitro stimulation of human PBMC cells at the indicated concentrations (a, b) or a final concentration of 3 μM (c) and read-out after 48 h. a, dose-dependent stimulation of...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Video |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!